HIV-inhibitory natural products part 71 - Cyanovirin-N defines a new class of antiviral agent targeting N-linked, high-mannose glycans in an oligosaccharide-specific manner

被引:135
作者
Bolmstedt, AJ
O'Keefe, BR
Shenoy, SR
Mcmahon, JB
Boyd, MR
机构
[1] NCI, Lab Drug Discovery Res & Dev, Div Basic Sci, Frederick, MD 21702 USA
[2] Gothenburg Univ, Dept Clin Virol, S-41124 Gothenburg, Sweden
关键词
D O I
10.1124/mol.59.5.949
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Herein we report that the novel HIV-inactivating protein cyanovirin-N (CV-N) targets specific, N-linked high-mannose oligosaccharides found on the viral envelope of HIV-1. First, we released the oligosaccharides by PnGase-treatment of HIV-gp120 (containing high-mannose, hybrid-type and complex-type oligosaccharides) or HSV-1 gC (containing only complex-type). Then, in an affinity chromatographic system, we found that CV-N bound to the free oligosaccharides from gp120 but not from gC-1, suggesting that high-mannose oligosaccharides constitute a target structure for CV-N. This was supported by the affinity of CV-N for high-mannose glycans released from gp120 by endo-H as well as high-mannose glycans released from castanospermine-treated HSV-1 gC. Furthermore, free Man-8 or Man-9 oligosaccharides partially inhibited the binding of CV-N to gp120, although neither oligosaccharides smaller than Man-7 nor monosaccharides interfered with CV-N/gp120 interaction, thereby establishing the oligosaccharide-specific affinity of CV-N to high-mannose glycans. This affinity for high-mannose oligosaccharides may explain the broad antiviral activity of CV-N against human and primate immunodeficiency retroviruses as well as certain other viruses that carry these oligosaccharides.
引用
收藏
页码:949 / 954
页数:6
相关论文
共 25 条
[1]   PRIMATE CYTOMEGALOVIRUS GLYCOPROTEINS - LECTIN-BINDING PROPERTIES AND SENSITIVITIES TO GLYCOSIDASES [J].
BENKO, DM ;
GIBSON, W .
JOURNAL OF VIROLOGY, 1986, 59 (03) :703-713
[2]   Solution structure of cyanovirin-N, a potent HIV-inactivating protein [J].
Bewley, CA ;
Gustafson, KR ;
Boyd, MR ;
Covell, DG ;
Bax, A ;
Clore, GM ;
Gronenborn, AM .
NATURE STRUCTURAL BIOLOGY, 1998, 5 (07) :571-578
[3]   EFFECTS OF MUTATIONS IN GLYCOSYLATION SITES AND DISULFIDE BONDS ON PROCESSING, CD4-BINDING AND FUSION ACTIVITY OF HUMAN-IMMUNODEFICIENCY-VIRUS ENVELOPE GLYCOPROTEINS [J].
BOLMSTEDT, A ;
HEMMING, A ;
FLODBY, P ;
BERNTSSON, P ;
TRAVIS, B ;
LIN, JPC ;
LEDBETTER, J ;
TSU, T ;
WIGZELL, H ;
HU, SL ;
OLOFSSON, S .
JOURNAL OF GENERAL VIROLOGY, 1991, 72 :1269-1277
[4]   Discovery of cyanovirin-N, a novel human immunodeficiency virus-inactivating protein that binds viral surface envelope glycoprotein gp120: Potential applications to microbicide development [J].
Boyd, MR ;
Gustafson, KR ;
McMahon, JB ;
Shoemaker, RH ;
OKeefe, BR ;
Mori, T ;
Gulakowski, RJ ;
Wu, L ;
Rivera, MI ;
Laurencot, CM ;
Currens, MJ ;
Cardellina, JH ;
Buckheit, RW ;
Nara, PL ;
Pannell, LK ;
Sowder, RC ;
Henderson, LE .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (07) :1521-1530
[5]   INHIBITORS OF PROTEIN GLYCOSYLATION AND GLYCOPROTEIN PROCESSING IN VIRAL SYSTEMS [J].
DATEMA, R ;
OLOFSSON, S ;
ROMERO, PA .
PHARMACOLOGY & THERAPEUTICS, 1987, 33 (2-3) :221-286
[6]   Multiple antiviral activities of cyanovirin-N: Blocking of human immunodeficiency virus type 1 gp120 interaction with CD4 and coreceptor and inhibition of diverse enveloped viruses [J].
Dey, B ;
Lerner, DL ;
Lusso, P ;
Boyd, MR ;
Elder, JH ;
Berger, EA .
JOURNAL OF VIROLOGY, 2000, 74 (10) :4562-4569
[7]   Cyanovirin-N binds to gp120 to interfere with CD4-dependent human immunodeficiency virus type 1 virion binding, fusion, and infectivity but does not affect the CD4 binding site on gp120 or soluble CD4-induced conformational changes in gp120 [J].
Esser, MT ;
Mori, T ;
Mondor, I ;
Sattentau, QJ ;
Dey, B ;
Berger, EA ;
Boyd, MR ;
Lifson, JD .
JOURNAL OF VIROLOGY, 1999, 73 (05) :4360-4371
[8]  
EZEKOWITZ RAB, 1988, J CELL SCI, P121
[9]   INHIBITION OF HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION BY THE LECTIN JACALIN AND BY A DERIVED PEPTIDE SHOWING A SEQUENCE SIMILARITY WITH GP120 [J].
FAVERO, J ;
CORBEAU, P ;
NICOLAS, M ;
BENKIRANE, M ;
TRAVE, G ;
DIXON, JFP ;
AUCOUTURIER, P ;
RASHEED, S ;
PARKER, JW ;
LIAUTARD, JP ;
DEVAUX, C ;
DORNAND, J .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1993, 23 (01) :179-185
[10]  
GEYER H, 1988, J BIOL CHEM, V263, P11760